Discover how BIS™ based protocols can help you monitor and tailor anaesthesia for each patient.
Studies have shown reductions in the use of anaesthetic drugs by as much as 50% in patients monitored with BIS™ technology:
Optimal anaesthetic administration improves patient outcomes and satisfaction, and may facilitate faster recovery and discharge by reducing side effects and postoperative complications. Studies have shown that patients whose anaesthetic dosing was guided by BIS™ monitoring required less anaesthetic drug and experienced:
Studies show an 80% reduction in awareness has been demonstrated when using BIS™ monitoring compared to routine care in both intravenous (TIVA, total intravenous anaesthesia) and inhaled drug combinations in anaesthesia patients.6,7,8
With TIVA procedures, the incidence of awareness can be 5-10 times greater than with inhaled anaesthetics as a result of the short-acting nature of some intravenous anaesthetics used, along with the challenges of monitoring the patient’s level of consciousness. This is all the more reason that BIS™ monitoring is important — it may help reduce the incidence of awareness during TIVA procedures and during inhaled anaesthesia.9
"The prospective studies incorporating BIS™-based protocols provide proof of principle that a brain monitor can be effective in decreasing the incidence of AWR."10
– Author George Mashour, et al., in a clinical review on the prevention of intraoperative awareness with explicit recall.
"Anesthesia guided by BIS™ could improve anesthetic delivery and postoperative recovery from relatively deep anesthesia."11
– Authors Yodying Punjasawadwong, Aram Phongchiewboon, and Nutchanart Bunchungmongkol, in a clinical review of bispectral index for improving anaesthetic delivery and postoperative recovery.
"BIS™ monitoring is recommended as an option for all patients receiving total intravenous anesthetic (TIVA). BIS™ technology is also cost effective in this patient population due to the inability to measure end-tidal anesthetic concentration."12
– National Institute for Health and Clinical Excellence